等待开盘 09-20 09:30:00 美东时间
+0.410
+1.40%
Le programme favorisera le développement des soins oncologiques, faisant ainsi...
06-26 19:47
LB-100 IS SYNERGISTIC WITH WEE1 INHIBITION IN KILLING CANCER CELLS; FINDING OPENS NEW TREATMENT STRATEGY IN ADDITION TO THREE CURRENT LIXTE CLINICAL TRIALS
03-27 20:37
WALTHAM, Mass.--(BUSINESS WIRE)--Dec. 5, 2023--ImmunoGen, Inc.(Nasdaq: IMGN), a...
2023-12-05 07:30
10月17日,恒瑞医药宣布,将公司自主研发的1类新药、PD-1抑制剂卡瑞利珠单抗(商品名:艾瑞卡)与Rivoceranib(国内上市产品名称为阿帕替尼,商品名...
2023-10-17 12:51
Innovative Multimillion-Dollar Grant Was Created in 2022 to Drive Biopharma Industry to Speed Development of Pancreatic Cancer Therapies BOSTON, SAN DIEGO, and CALGARY, AB, Sept. 26, 2023 /P...
2023-09-26 19:00